company-page-background
Johnson & Johnson Logo
Johnson & Johnson
 3.8
(224 Reviews)

Johnson & Johnson News

Johnson & Johnson logo
Johnson & Johnson
KSU | The Sentinel NewspaperJanuary 18, 2021

" This report also covers the impact of COVID-19 on the global market. The pandemic caused by Coronavirus (COVID-19) has affected every aspect of life globally, including the business sector. This has brought along several changes in market conditions. Reports Monitor has added a new report in its large database titled Global .

Human Fibrinogen Market 2021 Growing with Major Eminent Key Players: CSL Behring, Baxter, Johnson & Johnson(Ethicon), LFB Group, etc.
KSU | The Sentinel Newspaper
Human Fibrinogen Market 2021 Growing with Major Eminent Key Players: CSL Behring, Baxter, Johnson & Johnson(Ethicon), LFB Group, etc.
https://ksusentinel.com/2021/01/18/human-fibrinogen-market-2021-growing-with-major-eminent-key-players-csl-behring-baxter-johnson-johnsonethicon-lfb-group-etc/
Johnson & Johnson logo
Johnson & Johnson
KSU | The Sentinel NewspaperJanuary 18, 2021

The report attempts to offer high-quality and accurate analysis of the Global Arachnoid Cysts Treatment Market , keeping in view about the current market scenario as COVID 19 is greatly impacting overall world economy. It also focuses on competitive intelligence, and technological risks and advancements, and other important subjects.

Impact of Covid-19 on Arachnoid Cysts Treatment Market 2020-2028 – Medtronic, Johnson & Johnson, B. Braun Melsungen, GE Healthcare, Siemens Healthcare, Fujifilm SonoSite, etc.
KSU | The Sentinel Newspaper
Impact of Covid-19 on Arachnoid Cysts Treatment Market 2020-2028 – Medtronic, Johnson & Johnson, B. Braun Melsungen, GE Healthcare, Siemens Healthcare, Fujifilm SonoSite, etc.
https://ksusentinel.com/2021/01/18/impact-of-covid-19-on-arachnoid-cysts-treatment-market-2020-2028-medtronic-johnson-johnson-b-braun-melsungen-ge-healthcare-siemens-healthcare-fujifilm-sonosite-etc/
Johnson & Johnson logo
Johnson & Johnson
NeighborWebSJJanuary 18, 2021

The research report with title Global Medical Nebulizer Market Research Report 2020 announced by Pixion Market Research proposes an analysis of the Medical Nebulizer Industry comprising of significant information related to different product definitions, market classifications, geographical presence, and players in the industry chain structure.

Medical Nebulizer Market 2021-2026 : Competitive Study | Roche, 3M, Bayer, Johnson & Johnson, Novartis, Pfizer, Antares, Glaxosmithkline
NeighborWebSJ
Medical Nebulizer Market 2021-2026 : Competitive Study | Roche, 3M, Bayer, Johnson & Johnson, Novartis, Pfizer, Antares, Glaxosmithkline
https://neighborwebsj.com/uncategorized/1401439/medical-nebulizer-market-2021-2026-competitive-study-roche-3m-bayer-johnson-johnson-novartis-pfizer-antares-glaxosmithkline/
Johnson & Johnson logo
Johnson & Johnson
KSU | The Sentinel NewspaperJanuary 18, 2021

The Global Cetirizine Hydrochloride Market report provides a holistic evaluation of the market for the forecast period (2019-2025). The report comprises various segments as well as an analysis of the trends and factors that are playing a substantial role in the market.

Cetirizine Hydrochloride Market Benefit and Volume 2020 with Status and Prospect to 2026 | Johnson and Johnson, Mylan, Inc., Nicox SA
KSU | The Sentinel Newspaper
Cetirizine Hydrochloride Market Benefit and Volume 2020 with Status and Prospect to 2026 | Johnson and Johnson, Mylan, Inc., Nicox SA
https://ksusentinel.com/2021/01/18/cetirizine-hydrochloride-market-benefit-and-volume-2020-with-status-and-prospect-to-2026-johnson-and-johnson-mylan-inc-nicox-s-a/
Johnson & Johnson logo
Johnson & Johnson
WVLTJanuary 17, 2021

(CNN) -Early stage trials of Johnson & Johnson's experimental coronavirus vaccine show it generated an immune response in nearly all volunteers, with minimal side-effects, after a single dose. The company expects to report details of more advanced trials later this month and is hoping to apply for authorization from the US Food and Drug Administration soon after.

Johnson & Johnson coronavirus vaccine generates immune response, few side effects, in early trials
WVLT
Johnson & Johnson coronavirus vaccine generates immune response, few side effects, in early trials
https://www.wvlt.tv/2021/01/16/johnson-johnson-coronavirus-vaccine-generates-immune-response-few-side-effects-in-early-trials/
Johnson & Johnson logo
Johnson & Johnson
The HillJanuary 17, 2021

Anthony Fauci Anthony Fauci Sunday shows preview: Washington prepares for an inauguration and impeachment; coronavirus surges across the US Overnight Health Care: Biden unveils COVID-19 relief plan | Post-holiday surge hits new deadly records | Senate report faults 'broken' system for insulin price hikes Should there be a 'Secretary of Thought'?

Fauci: Approval of AstraZeneca and Johnson & Johnson vaccines likely 'weeks away' | TheHill
The Hill
Fauci: Approval of AstraZeneca and Johnson & Johnson vaccines likely 'weeks away' | TheHill
https://thehill.com/homenews/sunday-talk-shows/534620-fauci-approval-of-astrazeneca-and-jj-vaccines-likely-weeks-away
Johnson & Johnson logo
Johnson & Johnson
KSU | The Sentinel NewspaperJanuary 17, 2021

Tapentadol Market report provides in-depth statistics and analysis available on the market status of the Tapentadol key players and is a valuable method of obtaining guidance and direction for companies and business enterprise insider considering the Tapentadol market. It contains the analysis of drivers, challenges, and restraints impacting the industry.

Tapentadol Market Shows Strong Growth by 2025 | Johnson & Johnson, Ranbaxy Laboratories, IPCA Laboratories, Tirupati Medicare
KSU | The Sentinel Newspaper
Tapentadol Market Shows Strong Growth by 2025 | Johnson & Johnson, Ranbaxy Laboratories, IPCA Laboratories, Tirupati Medicare
https://ksusentinel.com/2021/01/17/tapentadol-market/
Johnson & Johnson logo
Johnson & Johnson
Atlanta Journal ConstitutionJanuary 17, 2021

The French country manor is 14,791 square feet and has eight bedrooms. According to the listing, "the home overlooks a pristine lake, lush pastures and in the distance a working 12 stall barn, riding arena with viewing deck, hay barn and a 1867 farmhouse with historic log cabin."

Dwayne ‘The Rock’ Johnson lists Atlanta estate for $7.5 million
Atlanta Journal Constitution
Dwayne ‘The Rock’ Johnson lists Atlanta estate for $7.5 million
https://www.ajc.com/life/radiotvtalk-blog/dwayne-the-rock-johnson-lists-atlanta-estate-for-75-million/6POOB2BSJBDUZCTZCYGMEIIN7Q/
Johnson & Johnson logo
Johnson & Johnson
Yahoo SportsJanuary 16, 2021

Johnson & Johnson's single-dose COVID-19 vaccine candidate looks promising based on initial results from the ongoing trial published in the New England Journal of Medicine . The phase 1-2a trial, which started in July 2020 in the U.S.

Experts call Johnson & Johnson's single-dose COVID vaccine 'very promising.' Here's what you need to know.
Yahoo Sports
Experts call Johnson & Johnson's single-dose COVID vaccine 'very promising.' Here's what you need to know.
https://sports.yahoo.com/what-to-know-johnson-johnson-single-dose-covid-vaccine-experts-very-promising-174410653.html
Johnson & Johnson logo
Johnson & Johnson
WGNO New OrleansJanuary 16, 2021

by: Ninette Sosa, Nexstar Media Wire Posted: / Updated: ARKANSAS (KNWA/KFTA) - Johnson & Johnson is close to wrapping up data analysis for Phase 3 of its COVID-19 vaccine trial. Janssen, the Belgian unit pharmaceutical division of Johnson & Johnson, reported approximately 45,000 people have participated in Phase 3 clinical trials, also known as ENSEMBLE, as of December.

Johnson & Johnson one-dose COVID-19 vaccine may be on horizon
WGNO New Orleans
Johnson & Johnson one-dose COVID-19 vaccine may be on horizon
https://wgno.com/news/johnson-johnson-one-dose-covid-19-vaccine-may-be-on-horizon/
Johnson & Johnson logo
Johnson & Johnson
KPRC Click2HoustonJanuary 16, 2021

Johnson & Johnson is in the third phase of trials for a coronavirus vaccine that would take only a single dose.

Johnson & Johnson in Phase 3 of one-dose vaccine trial
KPRC Click2Houston
Johnson & Johnson in Phase 3 of one-dose vaccine trial
https://www.click2houston.com/video/news/2021/01/16/johnson--johnson-in-phase-3-of-one-dose-vaccine-trial/
Johnson & Johnson logo
Johnson & Johnson
StockNews.comJanuary 16, 2021

While not all stocks on the Robinhood 100 list possess fundamental strength, Visa (V), Johnson & Johnson (JNJ), Walt Disney (DIS), and Uber (UBER) have made it to the list on more than just market hype. Newly emerging work and lifestyle trends and strong financials make these stocks appropriate to buy and hold this year we think.

V: 4 Robinhood Stocks to Own in 2021: Visa, Johnson & Johnson, Disney, and Uber
StockNews.com
V: 4 Robinhood Stocks to Own in 2021: Visa, Johnson & Johnson, Disney, and Uber
https://stocknews.com/news/v-jnj-dis-uber-4-robinhood-stocks-to-own-in-2021-visa-johnson/
Johnson & Johnson logo
Johnson & Johnson
KSU | The Sentinel NewspaperJanuary 16, 2021

Global Pediatric Healthcare Market - Scope of the Report "Pediatric Healthcare Market research report delivers a comprehensive study on production capacity, consumption, import and export for all major regions across the world. Report provides is a professional inclusive study on the current state for the market.

Pediatric Healthcare Market Business Opportunity to 2027 – Top Companies Wyeth, Johnson and Johnson, AxcanPharma, Sanofi
KSU | The Sentinel Newspaper
Pediatric Healthcare Market Business Opportunity to 2027 – Top Companies Wyeth, Johnson and Johnson, AxcanPharma, Sanofi
https://ksusentinel.com/2021/01/16/pediatric-healthcare-market-business-opportunity-to-2027-top-companies-wyeth-johnson-and-johnson-axcanpharma-sanofi/
Johnson & Johnson logo
Johnson & Johnson
The CourierJanuary 16, 2021

A new versatile research report on "Global Aesthetic Medicine Market Size, Share, Growth and Forecast 2020-2027" is aimed at promising a unique approach towards provides highly efficient and accurate market research services at extremely reasonable rates. Aesthetic Medicine is the wide-ranging, top-line market research document which combines breadth and depth of knowledge.

Aesthetic Medicine Market Analysis and Forecast Report 2020-2027 | Johnson & Johnson Services, Galderma Laboratories, Alma Lasers, Solta Medical
The Courier
Aesthetic Medicine Market Analysis and Forecast Report 2020-2027 | Johnson & Johnson Services, Galderma Laboratories, Alma Lasers, Solta Medical
https://www.mccourier.com/aesthetic-medicine-market-analysis-and-forecast-report-2020-2027-johnson-johnson-services-galderma-laboratories-alma-lasers-solta-medical/
Johnson & Johnson logo
Johnson & Johnson
Yahoo FinanceJanuary 15, 2021

Johnson & Johnson (JNJ) closed the most recent trading day at $160.65, moving +1.75% from the previous trading session. The stock outpaced the S&P 500's daily loss of 0.38%. Elsewhere, the Dow lost 0.22%, while the tech-heavy Nasdaq lost 0.12%.

Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know
Yahoo Finance
Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know
https://finance.yahoo.com/news/johnson-johnson-jnj-gains-market-224510576.html
Johnson & Johnson logo
Johnson & Johnson
Yahoo NewsJanuary 15, 2021

Dr. Marc Siegel breaks down promising new data on Johnson & Johnson's COVID-19 vaccine.

Johnson & Johnson vaccine 'more robust' than its predecessors: Dr. Siegel
Yahoo News
Johnson & Johnson vaccine 'more robust' than its predecessors: Dr. Siegel
https://news.yahoo.com/johnson-johnson-vaccine-more-robust-163040257.html
Johnson & Johnson logo
Johnson & Johnson
MintJanuary 15, 2021

Johnson & Johnson's vaccine will be another weapon in the fight against Covid-19. What do these findings say about how well it works and how it compares with others?

Is Johnson & Johnson’s single-shot Covid-19 vaccine a game changer?
Mint
Is Johnson & Johnson’s single-shot Covid-19 vaccine a game changer?
https://www.livemint.com/opinion/columns/is-johnson-johnson-s-single-shot-covid-19-vaccine-a-game-changer-11610685720777.html
Johnson & Johnson logo
Johnson & Johnson
Seeking AlphaJanuary 15, 2021

J&J has published a bit more on their trials of their adenovirus-vector candidate, with data on the immunogenicity of the vaccine in patients.

Johnson & Johnson, SinoVac And More
Seeking Alpha
Johnson & Johnson, SinoVac And More
https://seekingalpha.com/article/4399052-johnson-johnson-sinovac-and
Johnson & Johnson logo
Johnson & Johnson
WBIR.comJanuary 15, 2021

Clinical trials are underway in Knoxville for the Johnson & Johnson COVID-19 vaccine. It's a single-dose vaccine, instead of others which require two shots. KNOXVILLE, Tenn. - A COVID-19 vaccine that is undergoing clinical trials in Knoxville, at the Volunteer Research Group, is showing promise according to doctors with the study.

Johnson & Johnson COVID-19 vaccine showing promise after clinical trials in Knoxville
WBIR.com
Johnson & Johnson COVID-19 vaccine showing promise after clinical trials in Knoxville
https://www.wbir.com/article/news/health/coronavirus/johnson-johnson-covid-19-vaccine-with-trials-in-knoxville-showing-promise/51-5ff23065-b4b1-4bb2-8fdb-e40dda112dca
Johnson & Johnson logo
Johnson & Johnson
CBS DetroitJanuary 15, 2021

Researchers say Johnson and Johnson's coronavirus vaccine generates a durable immune response with minimal side effects.

Johnson & Johnson Close To Release Of Their COVID-19 Vaccine
CBS Detroit
Johnson & Johnson Close To Release Of Their COVID-19 Vaccine
https://detroit.cbslocal.com/video/5201179-johnson-johnson-close-to-release-of-their-covid-19-vaccine/